Key facts
- This page summarizes Reprogrammed Interchange LLC's Form 4 filing for Vor Biopharma Inc. (VOR).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Jan 2025, 19:42.
Reprogrammed Interchange LLC - 30 Dec 2024 Form 4 Insider Report for Vor Biopharma Inc. (VOR)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- VOR
- Reported as of
- 30 Dec 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Jan 2025, 19:42:04 UTC
- Next SEC filing
- 27 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Frank Huang, Manager of Reprogrammed Interchange LLC
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Reprogrammed Interchange LLC filed Form 4 for Vor Biopharma Inc. (VOR) on 02 Jan 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VOR
transaction
Common Stock
Purchase
- Transaction value
- Shares
- +38,974,101
- Change %
- Price
- Shares after
- 38,974,101
- Date
- 30 Dec 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VOR
transaction
Derivative
Warrant (Right to Buy)
Purchase
- Transaction value
- Shares
- +48,717,626
- Change %
- Price
- Shares after
- 48,717,626
- Date
- 30 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 48,717,626
- Exercise price
- $0.8380
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each share of Common Stock was purchased together with an accompanying Warrant to purchase 1.25 shares of Common Stock. The purchase price of the securities was $0.99425 per share and accompanying Warrant.
Footnote F2
The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.
Footnote F3
The Warrants are exercisable immediately. Notwithstanding the foregoing, the Reporting Persons shall not be entitled to exercise the Warrants to the extent that such exercise would cause the aggregate number of shares of Common Stock beneficially owned by the Reporting Person, their affiliates and any persons who are members of a Section 13(d) group with the Reporting Persons or their affiliates to exceed 9.99% of the total number of issued and outstanding shares of Common Stock of the Issuer following such exercise.